Piramal Pharma Solutions (PPS), a globally recognized contract development and manufacturing organization (CDMO), is preparing to exhibit its comprehensive suite…
Read More
AstraZeneca Deepens Oncology Footprint with $2bn Equity Investment in Summit Therapeutics to Advance Next-Generation Cancer Combinations
AstraZeneca has announced a landmark $2bn equity investment in Summit Therapeutics, marking a major strategic alignment between the pharmaceutical giants…
Read More
Made Scientific Expands US East Coast Footprint with Acquisition of Advanced Pennsylvania Cell Therapy Manufacturing Facility from National Resilience
The landscape of advanced therapeutics manufacturing received a significant boost as Made Scientific officially acquired an expansive 85,000-square-foot cell therapy…
Read More
GSK Expands Oncology Footprint with Chimagen Trispecific T-Cell Engager Deal for Multiple Myeloma
British pharmaceutical giant GSK has significantly deepened its footprint in the oncology sector by securing the global rights to an…
Read More
ABEC Expands US Biomanufacturing Footprint With New Wilson, North Carolina Facility
The global biotechnology and pharmaceutical engineering sector is witnessing a significant infrastructural expansion as ABEC prepares to officially open its…
Read More
